India is committed to control foot and mouth disease (FMD) in cat...
The March 4 meeting of the apex regulatory body, the Genetic Engin...
When AIDS (acquired immuno deficiency syndrome) hit the Indian sh...
Clinical trial supply market thrives in India With more...
Stategies of leading MNC's give equal importance to both countries...
The Protection and Utilization of Public Funded Intellectual Prop...
cry1c gene from Metahelix Life Sciences recieved the approval from...
Indian doctors achieve breakthrough in Nanogeneseq technology ...
India, preferred choice for clinical research As glo...
Concentrating on high-end products Instead of spending i...
New Page 1 "Time is right for BIO to organize a business mis...
Clinical research in India The unique position of India...
47% serve sponsors with a revenue range of more than $200 m...
New Page 1 "The size of the Indian market is quit...
The dispute triggered by the repeated instances of seizure of Ind...
—Stefan Borgas, CEO, Lonza, Switzerland Switzerland-base...
Dr Rajan George, executive VP and chief technology officer, Paladi...